Events

Outsourcing in Clinical Trials East Coast

Date/Time
Date(s) - 23 May 17 - 24 May 17
All Day

Location
King of Prussia
King of Prussia
Upper Merion
Pennsylvania

United States

Organizers
Arena

Loading Map....

Outsourcing in Clinical Trials East Coast 2017

This fast-growing event brings together the clinical operations and outsourcing community from the Pennsylvania, New Jersey, New York pharma, biotech and medical device regions and beyond.

Arena International’s 7th annual Outsourcing in Clinical Trials East Coast conference included highlight presentations from the leading representatives from large pharma, small to medium sized biotech and medical device companies, as well as experts from the FDA and Tufts CSDD.

Highlight presentations included an interactive expert interview with the Head of Portfolio Sourcing and Relationship Management at Merck, a lively panel discussion focusing on building preferred partnerships and keynote presentations from Ken Getz of Tufts CSDD and a focus on patient engagement with input from industry, the FDA and CISCRP.

The event also offers a perfect platform for networking and relationship building between sponsors and vendors to facilitate the formation of new partnerships and the strengthening of existing relationships.

OCT East will be returning on May 23-24 2016. Please get in touch if you would be interested in taking part!

Visit the event website here:

PCI Pharma Services will be exhibiting at this event on 23rd and 24th May

Leave a Reply

Your email address will not be published. Required fields are marked *

eighteen + 19 =

Explore the PCI Process Phase by Phase

PRE-CLINICAL
PHASE I
PHASE II
PHASE III
COMMERCIAL

Swipe to explore the PCI Process

PRE CLINICAL

pre-clinical-icon
  • Formulation Development
  • Analytical development/characterisation

PHASE 1

PCI Phase 1
  • Formulation Development
  • Analytical Development
  • Drug in capsule/vial technology (Xcelodose)®
  • Phase I product manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase I packaging and labelling
  • Storage and distribution

PHASE 2

PCI Phase 2
  • Formulation Optimization
  • Dosage Form Process Validation
  • Analytical Testing and Stability Services
  • Phase II Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase II packaging and labelling
  • Storage and distribution

PHASE 3

PCI Phase 3
  • Comparator Sourcing
  • Scale Up Studies
  • Phase III Product Manufacture
  • Tablets/Capsules
  • Blinding via over-encapsulation
  • Phase III packaging and labelling
  • Analytical testing and stability services
  • Storage and distribution

COMMERCIAL

PCI Commercial Phase
  • Scale up for commercial supply
  • Commercial product manufacture
  • Commercial packaging and labelling
  • Validation services
  • Analytical testing and stability services
  • Product release to market
  • Storage and distribution

PCI Points...

You told us what aspects you value as "very important" when choosing a vendor...

Why choose us...

Our global reach and localized support ensures PCI as a strategic partner remains focussed on delivering speed-to-market and the commercial success of our customers

PCI is a global company that focusses on delivering speed-to-market and the commercial success of our customers

Why choose us...